Found: 32
Select item for more details and to access through your institution.
Maximum tolerated dose: clinical endpoint for a bygone era?
- Published in:
- 2009
- By:
- Publication type:
- journal article
Enigma of fluorouracil and levamisole.
- Published in:
- 1995
- By:
- Publication type:
- Editorial
Two phase I, pharmacokinetic, and pharmacodynamic studies of DFP-10917, a novel nucleoside analog with 14-day and 7-day continuous infusion schedules.
- Published in:
- Investigational New Drugs, 2019, v. 37, n. 1, p. 76, doi. 10.1007/s10637-018-0602-0
- By:
- Publication type:
- Article
The Clinical Development of 9-Aminocamptothecin.
- Published in:
- Annals of the New York Academy of Sciences, 2000, v. 922, n. 1, p. 224, doi. 10.1111/j.1749-6632.2000.tb07041.x
- By:
- Publication type:
- Article
9-Aminocamptothecin and Beyond.
- Published in:
- Annals of the New York Academy of Sciences, 1996, v. 803, n. 1, p. 231, doi. 10.1111/j.1749-6632.1996.tb26393.x
- By:
- Publication type:
- Article
Clinical Pharmacology of 9-Aminocamptothecin.
- Published in:
- Annals of the New York Academy of Sciences, 1996, v. 803, n. 1, p. 324, doi. 10.1111/j.1749-6632.1996.tb26407.x
- By:
- Publication type:
- Article
Book Review.
- Published in:
- 1999
- By:
- Publication type:
- Book Review
Book review.
- Published in:
- 1997
- By:
- Publication type:
- Book Review
Metabolism of patupilone in patients with advanced solid tumor malignancies.
- Published in:
- Investigational New Drugs, 2013, v. 31, n. 3, p. 605, doi. 10.1007/s10637-012-9838-2
- By:
- Publication type:
- Article
Phase 2 study of carlumab (CNTO 888), a human monoclonal antibody against CC-chemokine ligand 2 (CCL2), in metastatic castration-resistant prostate cancer.
- Published in:
- Investigational New Drugs, 2013, v. 31, n. 3, p. 760, doi. 10.1007/s10637-012-9869-8
- By:
- Publication type:
- Article
A phase II clinical and pharmacokinetic study of intravenous exatecan mesylate (DX-8951f) in patients with untreated metastatic gastric cancer.
- Published in:
- Investigational New Drugs, 2005, v. 23, n. 5, p. 479, doi. 10.1007/s10637-005-2907-z
- By:
- Publication type:
- Article
Population pharmacokinetic analysis of oxaliplatin in adults and children identifies important covariates for dosing.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2015, v. 75, n. 3, p. 495, doi. 10.1007/s00280-014-2667-6
- By:
- Publication type:
- Article
A phase I pharmacokinetic study of bexarotene with paclitaxel and carboplatin in patients with advanced non-small cell lung cancer (NSCLC).
- Published in:
- 2012
- By:
- Publication type:
- Report
The effect of bexarotene on atorvastatin pharmacokinetics: results from a phase I trial of bexarotene plus chemotherapy in patients with advanced non-small cell lung cancer.
- Published in:
- 2012
- By:
- Publication type:
- Report
Dose-escalating and pharmacological study of bortezomib in adult cancer patients with impaired renal function: a National Cancer Institute Organ Dysfunction Working Group Study.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2011, v. 68, n. 6, p. 1439, doi. 10.1007/s00280-011-1637-5
- By:
- Publication type:
- Article
Tesetaxel, a new oral taxane, in combination with capecitabine: a phase I, dose-escalation study in patients with advanced solid tumors.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2011, v. 68, n. 6, p. 1565, doi. 10.1007/s00280-011-1639-3
- By:
- Publication type:
- Article
A pharmacokinetic and safety study of intravenous arsenic trioxide in adult cancer patients with renal impairment.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2010, v. 66, n. 2, p. 345, doi. 10.1007/s00280-009-1169-4
- By:
- Publication type:
- Article
Phase I and pharmacokinetic study of cisplatin and troxacitabine administered intravenously every 28 days in patients with advanced solid malignancies.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 65, n. 1, p. 167, doi. 10.1007/s00280-009-1020-y
- By:
- Publication type:
- Article
Phase I study of paclitaxel poliglumex administered weekly for patients with advanced solid malignancies.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 64, n. 2, p. 287, doi. 10.1007/s00280-008-0869-5
- By:
- Publication type:
- Article
Phase I study of cetuximab, erlotinib, and bevacizumab in patients with advanced solid tumors.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 63, n. 6, p. 1065, doi. 10.1007/s00280-008-0811-x
- By:
- Publication type:
- Article
Phase 0 clinical trials in oncology: a paradigm shift for early drug development?
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 63, n. 4, p. 703, doi. 10.1007/s00280-008-0789-4
- By:
- Publication type:
- Article
Cantuzumab mertansine in a three-times a week schedule: a phase I and pharmacokinetic study.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2008, v. 62, n. 5, p. 911, doi. 10.1007/s00280-007-0672-8
- By:
- Publication type:
- Article
Safety and anti-tumor activity of sorafenib (Nexavar<sup>®</sup>) in combination with other anti-cancer agents: a review of clinical trials.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2008, v. 61, n. 4, p. 535, doi. 10.1007/s00280-007-0639-9
- By:
- Publication type:
- Article
A phase II, pharmacokinetic, and biologic study of semaxanib and thalidomide in patients with metastatic melanoma.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2007, v. 59, n. 2, p. 165, doi. 10.1007/s00280-006-0255-0
- By:
- Publication type:
- Article
A phase I and pharmacologic study of weekly gemcitabine in combination with infusional 5-fluorodeoxyuridine and oral calcium leucovorin.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2003, v. 52, n. 6, p. 487, doi. 10.1007/s00280-003-0698-5
- By:
- Publication type:
- Article
A phase I study of 9-aminocamptothecin as a colloidal dispersion formulation given as a fortnightly 72-h infusion.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2003, v. 52, n. 4, p. 333, doi. 10.1007/s00280-003-0657-1
- By:
- Publication type:
- Article
A phase I and pharmacologic study of 9-aminocamptothecin administered as a 120-h infusion weekly to adult cancer patients.
- Published in:
- 2001
- By:
- Publication type:
- journal article
Human plasma carboxylesterase and butyrylcholinesterase enzyme activity: correlations with SN-38 pharmacokinetics during a prolonged infusion of irinotecan.
- Published in:
- 2001
- By:
- Publication type:
- journal article
Pharmacokinetics and pharmacodynamic effects of 5-fluorouracil given as a one-hour intravenous infusion.
- Published in:
- 2001
- By:
- Publication type:
- journal article
Utilizing pharmacokinetics/pharmacodynamics modeling to simultaneously examine free CCL2, total CCL2 and carlumab (CNTO 888) concentration time data.
- Published in:
- Journal of Clinical Pharmacology, 2013, v. 53, n. 10, p. 1020, doi. 10.1002/jcph.140
- By:
- Publication type:
- Article
Therapeutic Targeting of the Macrophage Immune Checkpoint CD47 in Myeloid Malignancies.
- Published in:
- Frontiers in Oncology, 2020, v. 9, p. 1, doi. 10.3389/fonc.2019.01380
- By:
- Publication type:
- Article
Therapeutic Targeting of the Macrophage Immune Checkpoint CD47 in Myeloid Malignancies.
- Published in:
- Frontiers in Oncology, 2020, v. 10, p. 1, doi. 10.3389/fonc.2019.01380
- By:
- Publication type:
- Article